Metraipolis › archive › dc_d9f136d370f0

NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis — Europe PMC PMID:41081106

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41081106
DOI
10.7717/peerj.20020
License (as archived)
solo-consultazione
Archived
2026-11-09T13:04:24.910Z
SHA-256 of the archived text
508793d9829a6d92d60d637ba192aae68d4e5110577d311468671e9d6cd52d6c
Stable URL of this page
https://metraipolis.com/documento/dc_d9f136d370f0

How to cite

NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis — Europe PMC PMID:41081106 — Europe PMC (en), https://europepmc.org/article/MED/41081106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9f136d370f0 (Metraipolis archive dc_d9f136d370f0, sha256 508793d9829a6d92d60d637ba192aae68d4e5110577d311468671e9d6cd52d6c)
BibTeX
@misc{dcd9f136d370f0,
  title = {NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis — Europe PMC PMID:41081106},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41081106},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9f136d370f0; sha256 508793d9829a6d92d60d637ba192aae68d4e5110577d311468671e9d6cd52d6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081106. Agents can read the archived copy with the MCP tool read_document.